Stock Earnings
Altimmune Inc (ALT) Becoming More Attractive for Investors
In a filing, Altimmune Inc revealed its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17
Menu
In a filing, Altimmune Inc revealed its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Altimmune Inc’s recent filing unveils that its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Altimmune Inc
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Altimmune Inc’s recent filing unveils that its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Pfizer Inc (PFE) was down -0.45 percent to $37.27 whereas it’s German partner BioNTech SE (BNTX) fell by 3.10 percent